ALD-401: Phase II data

The double-blind, U.S. Phase II RECOVER-Stroke trial in patients with neurological damage arising from an ischemic stroke showed that an intracarotid infusion of

Read the full 237 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE